Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001837607-24-000094
Filing Date
2024-11-13
Accepted
2024-11-13 16:08:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tmb-20241113x424b3.htm 424B3 1575238
2 GRAPHIC tmb-20241113x424b3_a001.jpg GRAPHIC 7565
  Complete submission text file 0001837607-24-000094.txt   1586944
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274094 | Film No.: 241454196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)